Literature DB >> 17208433

Hypoxia-inducible factors: central regulators of the tumor phenotype.

John D Gordan1, M Celeste Simon.   

Abstract

Low oxygen levels are a defining characteristic of solid tumors, and responses to hypoxia contribute substantially to the malignant phenotype. Hypoxia-induced gene transcription promotes characteristic tumor behaviors, including angiogenesis, invasion, metastasis, de-differentiation and enhanced glycolytic metabolism. These effects are mediated, at least in part, by targets of the hypoxia-inducible factors (HIFs). The HIFs function as heterodimers comprising an oxygen-labile alpha-subunit and a stable beta-subunit also referred to as ARNT. HIF-1alpha and HIF-2alpha stimulate the expression of overlapping as well as unique transcriptional targets, and their induction can have distinct biological effects. New targets and novel mechanisms of dysregulation place the HIFs in an ever more central role in tumor biology and have led to development of pharmacological inhibitors of their activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17208433      PMCID: PMC3215290          DOI: 10.1016/j.gde.2006.12.006

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  81 in total

1.  FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity.

Authors:  P C Mahon; K Hirota; G L Semenza
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

2.  Genetic evidence for a tumor suppressor role of HIF-2alpha.

Authors:  Till Acker; Antonio Diez-Juan; Julian Aragones; Marc Tjwa; Koen Brusselmans; Lieve Moons; Dai Fukumura; Maria Paz Moreno-Murciano; Jean-Marc Herbert; Angelika Burger; Johanna Riedel; Gerd Elvert; Ingo Flamme; Patrick H Maxwell; Désiré Collen; Mieke Dewerchin; Rakesh K Jain; Karl H Plate; Peter Carmeliet
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

3.  Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity.

Authors:  Benjamin J Moeller; Matthew R Dreher; Zahid N Rabbani; Thies Schroeder; Yiting Cao; Chuan Y Li; Mark W Dewhirst
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

4.  HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability.

Authors:  Jennifer S Isaacs; Yun Jin Jung; David R Mole; Sunmin Lee; Carlos Torres-Cabala; Yuen-Li Chung; Maria Merino; Jane Trepel; Berton Zbar; Jorge Toro; Peter J Ratcliffe; W Marston Linehan; Len Neckers
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

5.  A conserved family of prolyl-4-hydroxylases that modify HIF.

Authors:  R K Bruick; S L McKnight
Journal:  Science       Date:  2001-10-11       Impact factor: 47.728

6.  C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

Authors:  A C Epstein; J M Gleadle; L A McNeill; K S Hewitson; J O'Rourke; D R Mole; M Mukherji; E Metzen; M I Wilson; A Dhanda; Y M Tian; N Masson; D L Hamilton; P Jaakkola; R Barstead; J Hodgkin; P H Maxwell; C W Pugh; C J Schofield; P J Ratcliffe
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

7.  Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression.

Authors:  Y Makino; R Cao; K Svensson; G Bertilsson; M Asman; H Tanaka; Y Cao; A Berkenstam; L Poellinger
Journal:  Nature       Date:  2001-11-29       Impact factor: 49.962

8.  Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation.

Authors:  Joslyn K Brunelle; Eric L Bell; Nancy M Quesada; Kristel Vercauteren; Valeria Tiranti; Massimo Zeviani; Richard C Scarpulla; Navdeep S Chandel
Journal:  Cell Metab       Date:  2005-06       Impact factor: 27.287

9.  HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation.

Authors:  F Yu; S B White; Q Zhao; F S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

10.  FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.

Authors:  David Lando; Daniel J Peet; Jeffrey J Gorman; Dean A Whelan; Murray L Whitelaw; Richard K Bruick
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

View more
  204 in total

1.  COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion.

Authors:  Bart van de Sluis; Xicheng Mao; Yali Zhai; Arjan J Groot; Jeroen F Vermeulen; Elsken van der Wall; Paul J van Diest; Marten H Hofker; Cisca Wijmenga; Leo W Klomp; Kathleen R Cho; Eric R Fearon; Marc Vooijs; Ezra Burstein
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  Metabolic remodeling precedes mitochondrial outer membrane permeabilization in human glioma xenograft cells.

Authors:  Shivani Ponnala; Chandramu Chetty; Krishna Kumar Veeravalli; Dzung H Dinh; Jeffrey D Klopfenstein; Jasti S Rao
Journal:  Int J Oncol       Date:  2011-11-07       Impact factor: 5.650

Review 3.  Circulating biomarkers in advanced renal cell carcinoma: clinical applications.

Authors:  Maria Hernandez-Yanez; John V Heymach; Amado J Zurita
Journal:  Curr Oncol Rep       Date:  2012-06       Impact factor: 5.075

4.  Cells lacking the fumarase tumor suppressor are protected from apoptosis through a hypoxia-inducible factor-independent, AMPK-dependent mechanism.

Authors:  Chiara Bardella; Martina Olivero; Annalisa Lorenzato; Massimo Geuna; Julie Adam; Linda O'Flaherty; Pierre Rustin; Ian Tomlinson; Patrick J Pollard; Maria Flavia Di Renzo
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

5.  IACS-010759, a potent inhibitor of glycolysis-deficient hypoxic tumor cells, inhibits mitochondrial respiratory complex I through a unique mechanism.

Authors:  Atsuhito Tsuji; Takumi Akao; Takahiro Masuya; Masatoshi Murai; Hideto Miyoshi
Journal:  J Biol Chem       Date:  2020-04-14       Impact factor: 5.157

6.  Low-dose radiation exposure induces a HIF-1-mediated adaptive and protective metabolic response.

Authors:  R Lall; S Ganapathy; M Yang; S Xiao; T Xu; H Su; M Shadfan; J M Asara; C S Ha; I Ben-Sahra; B D Manning; J B Little; Z-M Yuan
Journal:  Cell Death Differ       Date:  2014-02-28       Impact factor: 15.828

7.  Imidazole-based alkaloid derivative LCB54-0009 suppresses ocular angiogenesis and lymphangiogenesis in models of experimental retinopathy and corneal neovascularization.

Authors:  Byung-Hak Kim; Junyeop Lee; Jun-Sub Choi; Dae Young Park; Ho Young Song; Tae Kyo Park; Chung-Hyun Cho; Sang-Kyu Ye; Choun-Ki Joo; Gou Young Koh; Tae-Yoon Kim
Journal:  Br J Pharmacol       Date:  2015-06-26       Impact factor: 8.739

8.  Erythrocytosis associated with a novel missense mutation in the HIF2A gene.

Authors:  Richard van Wijk; Scott Sutherland; Annet C W Van Wesel; Eric G Huizinga; Melanie J Percy; Marc Bierings; Frank S Lee
Journal:  Haematologica       Date:  2009-12-08       Impact factor: 9.941

9.  Heterozygosity for hypoxia inducible factor 1alpha decreases the incidence of thymic lymphomas in a p53 mutant mouse model.

Authors:  Jessica A Bertout; Shetal A Patel; Benjamin H Fryer; Amy C Durham; Kelly L Covello; Kenneth P Olive; Michael H Goldschmidt; M Celeste Simon
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

10.  Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo.

Authors:  Ivy Chung; Guangzhou Han; Mukund Seshadri; Bryan M Gillard; Wei-dong Yu; Barbara A Foster; Donald L Trump; Candace S Johnson
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.